Skip to content
NASDAQ · SERVICES-PREPACKAGED SOFTWARE · LARGE CAP

Certara, Inc. CERT

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$418.8M
▲ 8.7% YoY
$-1.6M
$94.6M
▲ 19.9% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Certara provides biosimulation science, technology, and consulting services for Model-Informed Drug Development in the global biopharmaceutical and biotech industry. Its Phoenix PK/PD suite is software for managing, analyzing and reporting pharmacokinetic, pharmacodynamic and toxicokinetic data. As of December 31, 2025, the company employed 1,576 professionals in 28 countries, including 1,515 full-time employees and 61 part-time employees. It has worked with more than 2,600 life sciences companies and academic institutions and collaborated on more than 10,000 customer projects in the last decade. Certara was formed in 2008 through the combination of Tripos International and Pharsight Corporation, and Certara, Inc. was incorporated in Delaware on June 27, 2017.

Written from the business description in Certara, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.

Growth

USD 418.8M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 418.8 · Net income -1.6
150M300M-20M-40M
201920222025
Compound annual growth
+7.7%
+11.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +11.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−0 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating 5.0% · Net -0.4%
5%-10%-20%
201920222025
ROE
FY2025 · ROE -0.2%
0.5%1.0%-2.0%-4.0%-6.0%
201920222025
Three returns, three denominators.

Each USD of equity lost 0 cents this year.

Cash & shareholders

USD 42.6M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 94.6
40M80M
201920222025
Net buybacks $M Dividends $M
FY2025 · Dividends · · Net buybacks 42.6
15M30M-150M-300M
20192020202320242025

USD 42.6M in buybacks went back to shareholders in a year without profit.

Total assetsUSD 1.6B
EquityUSD 1.1B
CashUSD 189.4M
Gross debtUSD 293.1M
Net debtUSD 103.7M
Current ratio2.05×

Net debt stands at 10% of equity.

The 7-year record

7 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
CERT, 7-year financial record
Metric 2025202420232022202120202019
Revenue $B0.40.40.40.30.30.20.2
Operating income $B0.0−0.0−0.00.00.0−0.00.0
EBITDA $B0.10.10.00.00.0−0.00.0
Income tax $B0.0−0.00.00.00.0−0.0−0.0
Net income $B−0.0−0.0−0.10.0−0.0−0.0−0.0
Free cash flow $B0.10.10.10.10.10.00.0
EPS, diluted $−0.01−0.08−0.350.09−0.09−0.37−0.07
Dividend / sh $◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————
ROE %−0.2−1.1−5.21.4−1.4−7.5−1.8
Shares out B0.160.160.160.160.160.15◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 26 reconciliationsAUDITED

Reconciled in 7 of the 7 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 12 checks were skipped: EPS is not tagged before 2019. 12 checks were skipped: revenue is not tagged before 2019.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Prepackaged Software
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image